Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms by rss feed | May 13, 2021 | News Feeds Researchers in the UK have provided evidence that Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine induces effective immune responses in patients with myeloproliferative neoplasms. Read Original Copy